Editorial: Pharmacological and nutritional approaches to metabolic associated fatty liver disease: a step towards achieving SDG 3

Mahmut Bodur; Bojana Vidović; Anastasios Nikolaou; Birsen Yilmaz

doi:10.3389/fphar.2026.1802444

Editorial: Pharmacological and nutritional approaches to metabolic associated fatty liver disease: a step towards achieving SDG 3

Front Pharmacol. 2026 Feb 17:17:1802444. doi: 10.3389/fphar.2026.1802444. eCollection 2026.

Authors

Mahmut Bodur¹, Bojana Vidović², Anastasios Nikolaou³, Birsen Yilmaz^{4

5}

Affiliations

¹ Department of Nutrition and Dietetics, Faculty of Health Sciences, Ankara University, Ankara, Türkiye.
² Department of Bromatology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.
³ Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.
⁴ Department of Biological Sciences, Tata Institute of Fundamental Research, Hyderabad, India.
⁵ Advanced Research Unit on Metabolism, Development and Ageing (ARUMDA), Tata Institute of Fundamental Research, Hyderabad, India.

No abstract available

Keywords: SLC11A1; gut-liver axis; metabolic associated fatty liver disease; metabolic syndrome; pharmacological targets; precision nutrition; public health; resmetirom.

Publication types

Editorial